Shenyang Sinqi Pharmaceutical Co., Ltd(1977—2014)
Release time:2019-01-11 author:SINQI

On March 24, 1977, Shenyang Sinqi Pharmaceutical Co., Ltd., formerly known as Shenyang Sinqi Pharmaceutical Co., Ltd., was established.

On May 9, 1980, shenyang tiexi district Sinqi commune pharmaceutical factory was renamed as shenyang Sinqi pharmaceutical factory.

On December 31, 1989, liu jidong served as the acting director of shenyang Sinqi pharmaceutical factory.

On July 12, 1993, the first third-generation quinolone ciprofloxacin hydrochloride eye drops were launched in China.

On January 19, 1994, ofloxacin eye cream, the first ophthalmic gel product in China, was put on the market.

On January 11, 1996, China's first non-steroidal anti-inflammatory drug product "difei" brand diclofenac sodium eye drops went on the market.

In 1998, the Sinqi zhangshi factory invested by Sinqi pharmaceutical factory in shenyang economic and technological development zone was completed and put into operation.

On October 24, 1999, the first anti-fungal fluconazole eye drops product "pufen" was launched in China.

On July 5, 2000, shenyang Sinqi pharmaceutical factory carried out system reform and established shenyang Sinqi pharmaceutical co., LTD. The company precisely locates the ophthalmology field, establishes efficient management and incentive mechanism, and the enterprise is full of vitality.

On October 25, 2001, juming, an antibacterial, anti - inflammatory, anti - viral eye drops, was first marketed in China.

In 2004, liaoning provincial economic committee awarded Sinqi pharmaceutical r&d center the title of "liaoning provincial enterprise technology center".

On November 15, 2005, the first atropine sulfate eye gel product "dishan" was launched in China.

In 2006, Sinqi pharmaceutical sunshine charity fund was established, and the company actively participated in disaster relief, student aid, poverty relief and other relief work related to the society.

On November 9, 2007, China's first fifth-generation artificial tears vitamin A palmitate eye gel product "ziyang" was launched.

In 2007, Sinqi pharmaceutical research and development center was named "liaoning Sinqi ophthalmic drug engineering technology research center" by liaoning provincial department of science and technology.

On December 28, 2007, the first veal blood protein-free eye gel product "sukaojie" was launched in China.

On December 16, 2008, Sinqi pharmaceutical and ophthalmic branch of Chinese medical association launched the "Sinqi continuing education scholarship" project, which initiated the continuation of education model by Chinese ophthalmologists. In the form of continuing education scholarship, Sinqi pharmaceutical funded the Chinese society of ophthalmology to hold the continuing education class, and promoted the development of Chinese ophthalmology to continue the education career.

On April 9, 2009, the world's first fourth-generation quinolone eye gel product "diyou" went on the market.

In July 2009, liu jidong, chairman and general manager of Sinqi pharmaceutical co., ltd. personally invested 1 million yuan to establish Sinqi charitable foundation. The foundation's predecessor was Sinqi sunshine charity fund, and its establishment marked a new step for Sinqi charity relief activities.

In 2010, Sinqi pharmaceutical started to build an ophthalmic pharmacokinetic platform, which was also the first time for pharmaceutical companies to carry out professional research on ophthalmic pharmacology and pharmacokinetics in China.

On November 28, 2011, Sinqi completed the second restructuring and set up Shenyang Sinqi Pharmaceutical Co., Ltd. Liu jidong was the chairman and general manager of the company.

In July 2012, Shenyang Sinqi Pharmaceutical Co., Ltd. Marketing center moved to Beijing.

On May 13, 2013, Shenyang Sinqi Pharmaceutical Co., Ltd cooperated with ophthalmologist branch of China association of physicians to subsidize outstanding first-line residents to participate in education medical training and promote the development of ophthalmological level at the grassroots level.

In 2013, the world's first calf blood protein-free eye drops (single dose) product "sukogajie" was launched.

In 2014, the construction of Sinqi eyedrops qipanshan factory with an investment of 470 million yuan was completed, which passed the GMP certification and was put into full use.